ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Valipharma Limited

Valipharma Limited is an active company incorporated on 26 March 2004 with the registered office located in Bishops Stortford, Essex. Valipharma Limited was registered 21 years ago.
Status
Active
Active since incorporation
Company No
05085935
Private limited company
Age
21 years
Incorporated 26 March 2004
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 26 March 2025 (7 months ago)
Next confirmation dated 26 March 2026
Due by 9 April 2026 (5 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
Stonebridge House
Chelmsford Road
Hatfield Heath
CM22 7BD
England
Same address for the past 6 years
Telephone
024 76796496
Email
Unreported
Website
People
Officers
2
Shareholders
2
Controllers (PSC)
2
Secretary • Director • Chartered Accountant • British • Lives in UK • Born in Jun 1945
Valirx Plc
PSC
Valibioinnovation Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Andrew Manning Limited
Gerry Desler is a mutual person.
Active
140 High Street Management Limited
Gerry Desler is a mutual person.
Active
Corporate Battlefields Limited
Gerry Desler is a mutual person.
Active
Premier Education Group Limited
Gerry Desler is a mutual person.
Active
Valisrc Limited
Gerry Desler is a mutual person.
Active
Aralbest Limited
Gerry Desler is a mutual person.
Active
Desler Consulting Limited
Gerry Desler is a mutual person.
Active
Premier Sports Limited
Gerry Desler is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Decreased by 1 (-100%)
Total Assets
£308.53K
Decreased by £140.53K (-31%)
Total Liabilities
-£2.55M
Same as previous period
Net Assets
-£2.24M
Decreased by £140.53K (+7%)
Debt Ratio (%)
825%
Increased by 258.29% (+46%)
Latest Activity
Accounts Submitted
4 Months Ago on 17 Jun 2025
Confirmation Submitted
7 Months Ago on 26 Mar 2025
Subsidiary Accounts Submitted
1 Year 4 Months Ago on 14 Jun 2024
Confirmation Submitted
1 Year 7 Months Ago on 26 Mar 2024
Small Accounts Submitted
2 Years 2 Months Ago on 2 Sep 2023
Confirmation Submitted
2 Years 7 Months Ago on 26 Mar 2023
Small Accounts Submitted
3 Years Ago on 15 Sep 2022
Confirmation Submitted
3 Years Ago on 26 Mar 2022
Small Accounts Submitted
4 Years Ago on 2 Jul 2021
Confirmation Submitted
4 Years Ago on 26 Mar 2021
Get Credit Report
Discover Valipharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 12 Aug 2025
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Submitted on 12 Aug 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Submitted on 12 Aug 2025
Accounts made up to 31 December 2024
Submitted on 17 Jun 2025
Confirmation statement made on 26 March 2025 with no updates
Submitted on 26 Mar 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/23
Submitted on 14 Jun 2024
Audit exemption subsidiary accounts made up to 31 December 2023
Submitted on 14 Jun 2024
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
Submitted on 14 Jun 2024
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
Submitted on 14 Jun 2024
Confirmation statement made on 26 March 2024 with no updates
Submitted on 26 Mar 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year